0001354488-12-004584.txt : 20120827 0001354488-12-004584.hdr.sgml : 20120827 20120827123924 ACCESSION NUMBER: 0001354488-12-004584 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120822 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120827 DATE AS OF CHANGE: 20120827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunovative, Inc. CENTRAL INDEX KEY: 0001142790 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 651102237 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-53723 FILM NUMBER: 121056384 BUSINESS ADDRESS: STREET 1: 417 RUE ST-PIERRE STREET 2: SUITE 804 CITY: MONTREAL STATE: A8 ZIP: H2Y 2M3 BUSINESS PHONE: 514 840-3697 MAIL ADDRESS: STREET 1: 417 RUE ST-PIERRE STREET 2: SUITE 804 CITY: MONTREAL STATE: A8 ZIP: H2Y 2M3 FORMER COMPANY: FORMER CONFORMED NAME: Novo Energies Corp DATE OF NAME CHANGE: 20090626 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC WINE AGENCIES INC DATE OF NAME CHANGE: 20040622 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTICWINE AGENCIES INC DATE OF NAME CHANGE: 20040217 8-K 1 imun_8k.htm CURRENT REPORT imun_8k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):
August 22nd, 2012
 
Commission File #: 000-53723
 
IMMUNOVATIVE, INC.
(f/k/a Novo Energies Corporation)
 
(Exact name of registrant as specified in its charter)
Florida
(State or other jurisdiction of incorporation)

65-1102237
(IRS Employer Identification Number)

417, Rue St-Pierre, Suite 804
Montreal, QC
  (Address of principal US executive offices)

 Tel: (514) 840-3697
(Registrant’s telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))


 
 
 
 
ITEM 5.02 – DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.
 
            On August 22nd, 2012, Mr. Antonio Treminio resigned his position as Director of the Company and was replaced by Mr. Seth Shaw.  Mr. Shaw has been Vice President of the Company in charge of Strategic Planning.
 
Mr. Shaw, 33, started his career at American International Group (AIG) and has extensive experience building companies and securing financing from a broad range of both domestic and international institutional investors. Over the past seven years, he has been instrumental in securing more than $60 million in capital, in aggregate, for several small-cap and micro-cap companies.
 
ITEM 9.01 – FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit No.            Description

Resignation Letter Antonio Treminio

 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

 
IMMUNOVATIVE, INC
  
       
Date: August 27th, 2012
By:
/s/ Seth Shaw  
    Seth Shaw  
    Director  
       

EX-99.1 2 imun_ex991.htm LETTER imun_ex991.htm
EXHIBIT 99.1
 
THE BOARD OF DIRECTORS
 
OF

IMMUNOVATIVE INC.


The following is a true copy of the resolution duly adopted by the Board of Directors of this Corporation at a special meeting, notice to this meeting having been waived, held on August 22nd, 2012;

The Board of Directors which was present for this meeting & took active part therein was:

Antonio Treminio

WHEREAS there has been presented to and considered by this meeting a Motion to formally RESIGN my position as DIRECTOR of the company,

NOW THEREFORE BE IT RESOLVED that the corporation having considered this matter, has opened the floor to all those who voice a preference in the issue, has decided unanimously and RESOLVED that: I do hereby formally RESIGN as Director of the company, and do hereby, by affixing, my signature hereto, officially as my last corporate act of Director, DO HEREBY RESIGN.

The Director of the corporation, by affixing his signature hereto, does hereby formally resign, and shall allow the new Board to choose its Directors at a time and place of its choosing.


_____________________
Antonio Treminio, Director